Publications

  1. Das I, Mathur AK, Aqel B, Harnois D, Mao S, Taner CB, Croome KP. " To sleep-perchance to dream ": Daytime surgery start times for liver transplantation with ex situ normothermic machine perfusion. Liver Transpl 2024 Jul 1; 30 (7):763-767 Epub 2024 Feb 09
    View PubMed
  2. Overfield CJ, Padula CA, Paz-Fumagalli R, Montazeri SA, De la Garza-Ramos C, Elboraey MA, Croome KP, Lewis JT, Mao SA, Harnois DM, Frey G, McKinney JM, Ritchie C, Devcic Z, Lewis AR, Toskich BB. Histologic Findings of Sinusoidal Dilatation and Congestion in Liver Grafts Do Not Correlate with Hepatic Venous Anastomotic Gradients. Cardiovasc Intervent Radiol. 2024 Jun 6 Epub 2024 June 06
    View PubMed
  3. Chase RC, Koop AH, Shaikh M, Imperial RJ, Harnois DM, Loo NM, O'Brien JJ. Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy. Transfusion. 2024 Apr; 64 (4):755-760 Epub 2024 Mar 01
    View PubMed
  4. Danpanichkul P, Ng CH, Tan DJH, Muthiah MD, Kongarin S, Srisurapanont K, Kanjanakot Y, Duangsonk K, Huang DQ, Suzuki H, Harnois DM, Yang JD, Noureddin M, Wijarnpreecha K. The Global Burden of Early-Onset Biliary Tract Cancer: Insight From the Global Burden of Disease Study 2019. J Clin Exp Hepatol. 2024 Mar-Apr; 14 (2):101320 Epub 2023 Dec 14
    View PubMed
  5. Mercado LA, Gil-Lopez F, Chirila RM, Harnois DM. Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview. Diagnostics (Basel). 2024 Feb 9; 14 (4) Epub 2024 Feb 09
    View PubMed
  6. Nguyen JH, Toskich B, Paz-Fumagalli R, Fuqua PS, Harnois DM. Ex vivo intranodal administration of sirolimus. Transpl Immunol. 2023 Jun; 78:101840 Epub 2023 Apr 19
    View PubMed
  7. Mohamed MI, Markuson H, Toone HM, Sonnenwald SL, Dougherty MK, Musto KR, Harnois DM, Nguyen JH. Diaphragm preservation during combined abdominal and cardiothoracic deceased donor procurements. Liver Transpl. 2023 Mar 1; 29 (3):343-345 Epub 2022 Sept 09
    View PubMed
  8. De la Garza-Ramos C, Montazeri SA, Musto KR, Kapp MD, Lewis AR, Frey G, Paz-Fumagalli R, Ilyas S, Harnois DM, Majeed U, Patel T, Toskich B. Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis. J Hepatocell Carcinoma. 2023; 10:987-996 Epub 2023 June 23
    View PubMed
  9. Mercado LA, Bhangu HK, Calderon E, Mathur AK, Aqel B, Musto KR, Watt KD, Rosen CB, Bolan C, LeGout JD, Taner CB, Harnois DM, Croome KP. DCD Liver Grafts Can Safely Be Used for Recipients With Grade I-II Portal Vein Thrombosis: A Multicenter Analysis. Transplant Direct. 2022 Nov; 8 (11):e1392 Epub 2022 Oct 07
    View PubMed
  10. Mohamed MI, Markuson H, Toone HM, Sonnenwald SL, Dougherty MK, Musto KR, Harnois DM, Nguyen JH. [Not Available]. Liver Transpl. 2022 Sep 9; 343-345 Epub 2022 Sept 09
    View PubMed
  11. Montazeri SA, De la Garza-Ramos C, Lewis AR, Lewis JT, LeGout JD, Sella DM, Paz-Fumagalli R, Devcic Z, Ritchie CA, Frey GT, Vidal L, Croome KP, McKinney JM, Harnois D, Krishnan S, Patel T, Toskich BB. Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors. Eur J Nucl Med Mol Imaging. 2022 Sep; 49 (11):3892-3897 Epub 2022 Apr 20
    View PubMed
  12. Wadei HM, Burcin Taner C, Keaveny AP, Mai ML, Hodge DO, White LJ, Harnois DM, Mao SA, Jarmi T, Croome KP. The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center. Ann Hepatol. 2021 Sep-Oct; 24:100317 Epub 2021 Feb 03
    View PubMed
  13. Wijarnpreecha K, Ungprasert P, Panjawatanan P, Harnois DM, Zaver HB, Ahmed A, Kim D. COVID-19 and liver injury: a meta-analysis. Eur J Gastroenterol Hepatol. 2021 Jul 1; 33 (7):990-995
    View PubMed
  14. Wijarnpreecha K, Aby ES, Panjawatanan P, Lapumnuaypol K, Cheungpasitporn W, Lukens FJ, Harnois DM, Ungprasert P. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Gastroenterol. 2021 Jul-Aug; 34 (4):568-574 Epub 2021 Feb 26
    View PubMed
  15. Mousa OY, Juran BD, McCauley BM, Vesterhus MN, Folseraas T, Turgeon CT, Ali AH, Schlicht EM, Atkinson EJ, Hu C, Harnois D, Carey EJ, Gossard AA, Oglesbee D, Eaton JE, LaRusso NF, Gores GJ, Karlsen TH, Lazaridis KN. Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation. Hepatology. 2021 Jul; 74 (1):281-295 Epub 2021 June 15
    View PubMed
  16. Liou H, Mody K, Boyle AW, Keaveny AP, Croome KP, Burns JM, Harnois DM, Patel TC, Toskich B. Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response. Hepatology. 2021 Jul; 74 (1):525-527 Epub 2021 Apr 27
    View PubMed
  17. Wijarnpreecha K, Aby ES, Kim D, Ungprasert P, Cheungpasitporn W, Thongprayoon C, Lukens FJ, Harnois DM, Kroner PT. The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission. Eur J Gastroenterol Hepatol. 2021 Jun 1; 33 (6):894-898
    View PubMed
  18. Wijarnpreecha K, Werlang M, Panjawatanan P, Pungpapong S, Lukens FJ, Harnois DM, Ungprasert P. Smoking & risk of advanced liver fibrosis among patients with primary biliary cholangitis: A systematic review & meta-analysis. Indian J Med Res. 2021 Jun; 154 (6):806-812
    View PubMed
  19. Wijarnpreecha K, Scribani M, Raymond P, Harnois DM, Keaveny AP, Ahmed A, Kim D. PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-Related Mortality in the United States. Clin Gastroenterol Hepatol. 2021 May; 19 (5):1064-1066 Epub 2020 Apr 29
    View PubMed
  20. Eaton JE, Welle CL, Bakhshi Z, Sheedy SP, Idilman IS, Gores GJ, Rosen CB, Heimbach JK, Taner T, Harnois DM, Lindor KD, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis. Hepatology. 2021 May; 73 (5):1868-1881 Epub 2021 Apr 19
    View PubMed
  21. De la Garza-Ramos C, Muneer MS, Lewis JT, Harnois DM, Taner CB, Frey GT, Rosser B, Toskich BB. Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting. Radiol Case Rep. 2021 Apr; 16 (4):975-978 Epub 2021 Feb 15
    View PubMed
  22. Wijarnpreecha K, Aby ES, Panjawatanan P, Kroner PT, Harnois DM, Palmer WC, Ungprasert P. Hereditary hemochromatosis and risk of joint replacement surgery: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021 Jan; 33 (1):96-101
    View PubMed
  23. De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. J Hepatocell Carcinoma. 2021; 8:861-870 Epub 2021 July 30
    View PubMed
  24. Wijarnpreecha K, Aby ES, Ghoz H, Cheungpasitporn W, Lukens FJ, Harnois DM, Ungprasert P. Statins and Risk of Cholangiocarcinoma: A Systematic Review and Meta-analysis. J Gastrointestin Liver Dis. 2020 Dec 13; 29 (4):629-635
    View PubMed
  25. Wijarnpreecha K, Scribani M, Raymond P, Harnois DM, Keaveny AP, Ahmed A, Kim D. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. J Gastroenterol Hepatol. 2020 Oct; 35 (10):1789-1794 Epub 2020 Apr 12
    View PubMed
  26. Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM. Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival. Transplantation. 2020 Oct; 104 (10):2105-2112
    View PubMed
  27. Osman KT, Maselli DB, Idilman IS, Rowan DJ, Viehman JK, Harmsen WS, Harnois DM, Carey EJ, Gossard AA, LaRusso NF, Lindor KD, Venkatesh SK, Eaton JE. Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis. J Clin Gastroenterol. 2020 Sep 23 Epub 2020 Sept 23
    View PubMed
  28. Chaney A, Rawal B, Harnois D, Keaveny A. Nutritional Assessment and Malnutrition in Patients With Cirrhosis. Gastroenterol Nurs. 2020 Jul/Aug; 43 (4):284-291
    View PubMed
  29. Wijarnpreecha K, Panjawatanan P, Cheungpasitporn W, Lukens FJ, Harnois DM, Pungpapong S, Ungprasert P. The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. J Gastrointestin Liver Dis. 2020 Jun 3; 29 (2):211-217 Epub 2020 June 03
    View PubMed
  30. Wijarnpreecha K, Panjawatanan P, Mousa OY, Cheungpasitporn W, Lukens FJ, Nguyen JH, Pungpapong S, Harnois DM, Ungprasert P. Survival after liver transplant in recipients older than 70 years: A systematic review and meta-analysis Indian J Transplant. 2020; 14(1):63-7.
  31. Satiya J, Mousa OY, Gupta K, Trivedi S, Oman SP, Wijarnpreecha K, Harnois DM, Corral JE. Diagnostic yield of magnetic resonance imaging for cholangiocarcinoma in primary sclerosing cholangitis: a meta-analysis. Clin Exp Hepatol. 2020 Feb; 6 (1):35-41 Epub 2020 Feb 17
    View PubMed
  32. Ruiz JN, Kroner PT, Wijarnpreecha K, Corral JE, Harnois DM, Lukens FJ. Increased odds of cholangiocarcinoma in Hispanics: results of a nationwide analysis. Eur J Gastroenterol Hepatol. 2020 Jan; 32 (1):116-119
    View PubMed
  33. Devcic Z, Elboraey M, Vidal L, Mody K, Harnois D, Patel T, Toskich BB. Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum. Semin Intervent Radiol. 2019 Oct; 36 (4):287-297 Epub 2019 Oct 31
    View PubMed
  34. Mousa OY, Nguyen JH, Ma Y, Rawal B, Musto KR, Dougherty MK, Shalev JA, Harnois DM. Evolving Role of Liver Transplantation in Elderly Recipients. Liver Transpl. 2019 Sep; 25 (9):1363-1374 Epub 2019 July 20
    View PubMed
  35. Mallea J, Bolan C, Cortese C, Harnois D. Cystic Fibrosis-Associated Liver Disease in Lung Transplant Recipients. Liver Transpl. 2019 Aug; 25 (8):1265-1275 Epub 2019 June 25
    View PubMed
  36. Zheng D, Trynda J, Williams C, Vold JA, Nguyen JH, Harnois DM, Bagaria SP, McLaughlin SA, Li Z. Sexual dimorphism in the incidence of human cancers. BMC Cancer. 2019 Jul 12; 19 (1):684 Epub 2019 July 12
    View PubMed
  37. Wijarnpreecha K, Werlang M, Panjawatanan P, Kroner PT, Mousa OY, Pungpapong S, Lukens FJ, Harnois DM, Ungprasert P. Association between Smoking and Risk of Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. J Gastrointestin Liver Dis 2019 Jun 1; 28:197-203 Epub 2019 June 01
    View PubMed
  38. Yang JD, Addissie BD, Mara KC, Harmsen WS, Dai J, Zhang N, Wongjarupong N, Ali HM, Ali HA, Hassan FA, Lavu S, Cvinar JL, Giama NH, Moser CD, Miyabe K, Allotey LK, Algeciras-Schimnich A, Theobald JP, Ward MM, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Srivastava S, Rinaudo JA, Gores GJ, Feng Z, Marrero JA, Roberts LR. GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score. Cancer Epidemiol Biomarkers Prev. 2019 Mar; 28 (3):531-538 Epub 2018 Nov 21
    View PubMed
  39. Lee DD, Samoylova M, Mehta N, Musto KR, Roberts JP, Yao FY, Harnois DM. The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. Liver Transpl. 2019 Feb; 25 (2):228-241
    View PubMed
  40. Zheng D, Williams C, Vold JA, Nguyen JH, Harnois DM, Bagaria SP, McLaughlin SA, Li Z. Regulation of sex hormone receptors in sexual dimorphism of human cancers. Cancer Lett. 2018 Dec 1; 438:24-31 Epub 2018 Sept 14
    View PubMed
  41. Corral JE, Mousa OY, Krishna M, Levink IJM, Pursell KR, Afsh M, Kroner PT, Harnois DM, Wolfsen HC, Wallace MB, Lukens FJ. Volumetric laser endomicroscopy in the biliary and pancreatic ducts: a feasibility study with histological correlation. Endoscopy. 2018 Nov; 50 (11):1089-1094 Epub 2018 June 18
    View PubMed
  42. Chadha RM, Dougherty MK, Musto KR, Harnois DM, Nguyen JH. Temporary Portomesenteric Decompression for Splenic Vein Aneurysm During Orthotopic Liver Transplant. Liver Transpl 2018 Oct; 24 (10):1485-1488
    View PubMed
  43. Lee DD, Croome KP, Musto KR, Melendez J, Tranesh G, Nakhleh R, Taner CB, Nguyen JH, Patel T, Harnois DM. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl. 2018 May; 24 (5):634-644
    View PubMed
  44. Nguyen JH, Harnois DM. Allograft Portacaval Shunt in Small-for-Size Liver in Deceased Donor Liver Transplant. Transplant Proc. 2018 Apr; 50 (3):930-932
    View PubMed
  45. Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol. 2018 Mar 28; 24 (12):1321-1331
    View PubMed
  46. Nguyen JH, Harnois DM. Incidence and Outcome of Small-for-Size Liver Grafts Transplanted in Adult Recipients. Transplant Proc. 2018 Jan - Feb; 50 (1):198-201
    View PubMed
  47. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation. 2017 Sep; 101 (9):2071-2078
    View PubMed
  48. Yang JD, Dai J, Singal AG, Gopal P, Addissie BD, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Gores GJ, Feng Z, Marrero JA, Roberts LR. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase. Cancer Epidemiol Biomarkers Prev. 2017 Jul; 26 (7):1085-1092 Epub 2017 Mar 03
    View PubMed
  49. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  50. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  51. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017 Apr 1; 3 (4):493-500
    View PubMed
  52. Lee DD, Croome KP, Harnois DM, Taner C, Patel TC. Caveat Emptor, Liver Transplantation for Intrahepatic Cholangiocarcinoma Liver Transplantation. 2017.
  53. Croome KP, Lee DD, Harnois D, Taner CB. Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma. PLoS One. 2017; 12 (1):e0170673 Epub 2017 Jan 25
    View PubMed
  54. Clayton DB, Palmer WC, Robison SW, Heckman MG, Chimato NT, Harnois DM, Francis DL. Colonoscopy bowel preparation quality improvement for patients with decompensated cirrhosis undergoing evaluation for liver transplantation. Clin Transplant. 2016 Oct; 30 (10):1236-1241
    View PubMed
  55. Chaney AJ, Harnois DM, Musto KR, Nguyen JH. Role Development of Nurse Practitioners and Physician Assistants in Liver Transplantation. Prog Transplant. 2016 Mar; 26: (1)75-81.
    View PubMed
  56. Werlang ME, Palmer WC, Boyd EA, Cangemi DJ, Harnois DM, Taner CB, Stancampiano FF. Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes. Clin Transplant. 2016 Jan; 30: (1)26-32.
    View PubMed
  57. Elfeki MA, Paz-Fumagalli R, Tiemeier AM, Pungpapong S, Sella DM, Frey GT, Musto KR, Nguyen JH, Harnois DM. Choice of Partial Splenic Embolization Technique in Liver Transplant Recipients Correlates With Risk of Infectious Complications. Transplant Proc. 2015 Dec; 47 (10):2932-8
    View PubMed
  58. Elfeki MA, Pungpapong S, Genco PV, Nakhleh RE, Nguyen JH, Harnois DM. Graft-versus-host disease after orthotopic liver transplantation: multivariate analysis of risk factors. Clin Transplant. 2015 Dec; 29: (12)1063-6.
    View PubMed
  59. Croome KP, Lee DD, Burns JM, Musto K, Paz D, Nguyen JH, Perry DK, Harnois DM, Taner CB. The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma. Am J Transplant. 2015 Oct; 15 (10):2704-11 Epub 2015 May 12
    View PubMed
  60. Chaiteerakij R, Zhang X, Addissie BD, Mohamed EA, Harmsen WS, Theobald PJ, Peters BE, Balsanek JG, Ward MM, Giama NH, Moser CD, Oseini AM, Umeda N, Venkatesh S, Harnois DM, Charlton MR, Yamada H, Satomura S, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015 May; 21 (5):599-606
    View PubMed
  61. Elfeki MA, Genco PV, Pungpapong S, Nakhleh RE, Nguyen JH, Harnois DM. Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report. Transplant Proc. 2014 Sep; 46 (7):2422-5
    View PubMed
  62. Patel T, Harnois D. Assessment of response to therapy in hepatocellular carcinoma. Ann Med. 2014 May; 46 (3):130-7 Epub 2014 Apr 10
    View PubMed
  63. Harnois DM, Yataco ML, Nakhleh RE. Recurrence of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis after transplantation. Clin Liver Dis (Hoboken). 2014 Apr; 3 (4):90-92 Epub 2014 Apr 28
    View PubMed
  64. Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts LR. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2013 Jun; 36 (3):714-23 Epub 2012 Oct 24
    View PubMed
  65. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012 Jul; 143 (1):88-98.e3; quiz e14 Epub 2012 Apr 12
    View PubMed
  66. Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl. 2012 May; 18(5):594-601.
    View PubMed
  67. Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD. High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther. 2011 Nov; 34 (10):1185-92 Epub 2011 Sept 29
    View PubMed
  68. Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011 Sep; 106 (9):1638-45 Epub 2011 May 10
    View PubMed
  69. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17 (6):641-9
    View PubMed
  70. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104.
    View PubMed
  71. Begum R, Harnois D, Satyanarayana R, Krishna M, Halling KC, Kim GP, Nguyen JH, Keaveny AP. Retransplantation for donor-derived neuroendocrine tumor. Liver Transpl. 2011 Jan; 17(1):83-7.
    View PubMed
  72. Albright JB, Bonatti H, Stauffer J, Dickson RC, Nguyen J, Harnois D, Jeanpierre C, Hinder R, Steers J, Chua H, Aranda-Michel J. Colorectal and anal neoplasms following liver transplantation. Colorectal Dis. 2010 Jul; 12(7):657-66.
    View PubMed
  73. Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JH, Harnois DM. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010 May; 10 (5):1263-7
    View PubMed
  74. Panjala C, Kodali L, Harnois DM, Wadei HM, Mai ML, Gonwa TA, Ahsan N. Impact of iothalamate clearance generated serum creatinine on MELD score and organ allocation in liver transplant recipients. Am J Transplant. 2010 Apr; 10(Sp Iss SI Suppl 4):357-8.
  75. Treeprasertsuk S, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Schmoll J, Hoskin T, Thapa P, Enders F, Lindor KD. The predictors of the presence of varices in patients with primary sclerosing cholangitis. Hepatology. 2010 Apr; 51 (4):1302-10
    View PubMed
  76. Hughes CB, Dickson RC, Krishna M, Willingham DL, Satyanarayana R, Harnois DM, Keaveny AP, Rosser B, Aranda-Michel J, Kramer DJ, Hellinger W, Mendez J. HCV recurrence in HIV-infected patients after liver transplant. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr; 9(2):87-93. Epub 2010 Mar 31.
    View PubMed
  77. Stauffer JA, Steers JL, Bonatti H, Aranda-Michel J, Dickson RC, Harnois DM, Nguyen JH. Liver transplantation and pancreatic resection: a single-center experience and a review of the literature. Liver Transpl. 2009 Dec; 15(12):1728-37.
    View PubMed
  78. Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, Steers JL, Harnois DM, Kramer DJ. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc. 2009 Nov; 84 (11):973-8
    View PubMed
  79. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15 (9):1028-35
    View PubMed
  80. Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009 Sep; 50 (3):808-14
    View PubMed
  81. Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009 Jul; 137(1):110-8. Epub 2009 Apr 09.
    View PubMed
  82. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS, Keaveny AP, Aranda-Michel J, Satyanarayana R, Rosser BG, Hinder RA, Steers JL, Hughes CB. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009 Mar-Apr; 23(2):168-73. Epub 2009 Feb 11.
    View PubMed
  83. Nguyen JH, Dickson RC, Harnois DM. A decade of liver transplantation at Mayo Clinic in Florida. Clin Transpl. 2008; 127-35.
    View PubMed
  84. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27.
    View PubMed
  85. Pungpapong S, Keaveny A, Raimondo M, Dickson R, Woodward T, Harnois D, Wallace M. Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices. Endoscopy. 2007 Aug; 39(8):673-80. Epub 2007 Jun 22.
    View PubMed
  86. Nields WW, Bonatti H, Harnois D, Hinder R, Nguyen J, Dickson RC, Aranda-Michel J, Randle HW. Squamous cell cancer, basal cell cancer and melanoma in a single liver transplant recipient. Eur. Surg. Acta Chir. Austriaca. 2007; 39(5):321-2.
  87. Hellinger WC, Bonatti H, Machicao VI, Yao JD, Brumble LM, Alvarez S, Weigand SD, Dickson RC, Harnois DM, Spivey JR, Stapelfeldt WH, Hughes CB, Nguyen JH, Steers JL. Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation. Mayo Clin Proc. 2006 Aug; 81(8):1029-33.
    View PubMed
  88. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl. 2006 Aug; 12(8):1244-52.
    View PubMed
  89. Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl. 2005 Jun; 11(6):656-62.
    View PubMed
  90. Levy C, Harnois DM, Angulo P, Jorgensen R, Lindor KD. Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study. Liver Int. 2005 Feb; 25(1):117-21.
    View PubMed
  91. Schmitt TM, Hughes CB, Bonatti H, Harnois DM, Nguyen JH, Dickson RC, Spivey JR, Steers JL. Gallbladder cancer and liver transplantation. Transpl Int. 2005 Jan; 18 (1):52-5
    View PubMed
  92. Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol. 2004 Oct; 38 (9):805-9
    View PubMed
  93. Bridges MD, May GR, Harnois DM. Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography. AJR Am J Roentgenol. 2004 Jun; 182: (6)1497-504.
    View PubMed
  94. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation. 2004 Jan 15; 77(1):84-92.
    View PubMed
  95. Scolapio JS, DeArment J, Hurley DL, Romano M, Harnois D, Weigand SD. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation. JPEN J Parenter Enteral Nutr. 2003 Nov-Dec; 27: (6)427-32.
    View PubMed
  96. Chabolla DR, Harnois DM, Meschia JF. Levetiracetam monotherapy for liver transplant patients with seizures. Transplant Proc. 2003 Jun; 35 (4):1480-1
    View PubMed
  97. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation. 2002 Jun 27; 73 (12):1904-9
    View PubMed
  98. Harnois DM, Angulo P, Jorgensen RA, Larusso NF, Lindor KD. High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol. 2001 May; 96(5):1558-62.
    View PubMed
  99. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000 Jan; 95 (1):204-7
    View PubMed
  100. Harnois DM, Steers J, Andrews JC, Rubin JC, Pitot HC, Burgart L, Wiesner RH, Gores GJ. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg. 1999 May; 5(3):192-9.
    View PubMed
  101. Harnois DM, Gores GJ, Ludwig J, Steers JL, Larusso NF, Wiesner RH. Are patients with cirrhotic-stage primary sclerosing cholangitis at risk for the development of hepatocelluar carcinoma? Review series: Hepatitis. 1999:8-9.
  102. Harnois DM, Que FG, Celli A, LaRusso NF, Gores GJ. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology. 1997 Oct; 26 (4):884-90
    View PubMed
  103. Harnois DM, Gores GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol. 1997 Sep; 27 (3):512-6
    View PubMed
  104. Harnois DM, Lindor KD. Primary sclerosing cholangitis: evolving concepts in diagnosis and treatment. Dig Dis. 1997 Jan-Apr; 15 (1-2):23-41
    View PubMed